PHASE 1/2 MULTICENTER CLINICAL TRIAL OF DONOR SPECIFIC TOLERANCE INDUCTION IN LIVING DONOR LIVER TRANSPLANTATION VIA ENGINEERED T CELLS WITH SUPPRESSING FUNCTIONS

被引:0
|
作者
Maehara, Y. [1 ]
Uchida, K. [1 ]
Takeda, K. [1 ]
Okumura, K. [1 ]
机构
[1] Juntendo Univ, Ctr Immunotherapy & Diag, Juntendo Daigaku Igakubu Daigakuin Igaku Kenkyuka, Tokyo, Japan
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
O001
引用
收藏
页码:A2 / A2
页数:1
相关论文
共 50 条
  • [1] Phase 1/2 multicenter clinical trial of donor specific tolerance induction in living donor liver transplantation via engineered T cells with suppressing functions
    Uchida, Koichiro
    AMERICAN JOURNAL OF TRANSPLANTATION, 2024, 24 (01) : S17 - S17
  • [2] PHASE 1/2 MULTICENTER CLINICAL TRIAL OF TOLERANCE INDUCTION IN LIVING DONOR LIVER TRANSPLANTATION VIA INDUCED T CELLS WITH SUPPRESSING FUNCTIONS
    Uchida, K.
    Takeda, K.
    Maehara, Y.
    Hirota, S.
    Okumura, K.
    CYTOTHERAPY, 2023, 25 (06) : S253 - S254
  • [3] Phase 1/2 Donor Antigen Specific Treg Based Suppressor T Cells Therapy Clinical Trial to Induce Operational Tolerance in Living Donor Liver Transplant Patients
    Uchida, K.
    Ohira, M.
    Hidaka, M.
    Ito, T.
    Hirata, Y.
    Watanabe, M.
    Goto, R.
    Taketomi, A.
    Hatano, E.
    Eguchi, S.
    Ohdan, H.
    Egawa, H.
    Takeda, K.
    Okumura, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S906 - S906
  • [4] A Phase 2 Clinical Trial of Donor Specific Tolerance Induction in Recipients of HLA Disparate Living Donor Kidney Allografts by Donor Stem Cell Infusion
    Leventhal, J.
    Abecassis, M.
    Miller, J.
    Gallon, L.
    Herzig, R.
    Tollerud, D. J.
    King, B.
    Ildstad, S. T.
    TRANSPLANTATION, 2012, 94 (10) : 148 - 148
  • [5] A CLINICAL TRIAL OF CELL THERAPY-BASED TOLERANCE INDUCTION IN LIVING DONOR LIVER TRANSPLANTATION: AN UPDATE
    Yamashita, Kenichiro
    Goto, Ryoichi
    Zaitsu, Masaaki
    Nagatsu, Akihisa
    Oura, Tetsu
    Watanabe, Masaaki
    Aoyagi, Takeshi
    Suzuki, Tomomi
    Shimamura, Tsuyoshi
    Kamiyama, Toshiya
    Sato, Norihiro
    Sugita, Junichi
    Hatanaka, Kanako
    Demetris, Anthony
    Bashuda, Hisashi
    Okumura, Ko
    Todo, Satoru
    TRANSPLANT INTERNATIONAL, 2015, 28 : 57 - 57
  • [6] A Phase 2 Clinical Trial of Donor Specific Tolerance Induction in Recipients of HLA Disparate Living Donor Kidney Allografts by Donor Stem Cell Infusion.
    Leventhal, J.
    Abecassis, M.
    Miller, J.
    Gallon, L.
    Herzig, R.
    Tollerud, D.
    King, B.
    Ildstad, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 27 - 27
  • [7] Induction of tolerance to living donor liver transplantation using myeloconditioning and donor stem cells infusion: A pilot study
    Donckier, V
    Troisi, R
    Ricciardi, S
    Colle, I
    Van Vlierberghe, H
    Toungouz, M
    Noens, L
    Le Moine, A
    de Hemptinne, B
    Goldman, M
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 551 - 551
  • [8] Stem Cells Versus Donor Specific Transfusions for Tolerance Induction in Living Donor Renal Transplantation: A Single Centre Experience
    Dave, S. D.
    TRANSPLANTATION, 2012, 94 (10) : 199 - 199
  • [9] Intraportal donor specific transfusion induce tolerance by donor type CD56-positive T cells in the graft liver in living related donor liver transplantation.
    Sato, Y
    Yamamoto, S
    Nakatsuka, H
    Oya, H
    Hatakeyama, K
    Abo, T
    Watanabe, H
    LIVER TRANSPLANTATION, 2004, 10 (06) : C73 - C73
  • [10] Induction of Operational Tolerance and Its Mechanism by IntraPortal Administration of Donor Specific Antigens in Living-Donor Liver Transplantation.
    Sato, Yoshinobu
    Yamamoto, Satoshi
    Oya, Hiroshi
    Kobayashi, Takashi
    Hara, Yoshiaki
    Kokai, Hidenaka
    Hatakeyama, Katsuyoshi
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 530 - 530